NZ717329A - Nitrogen-containing heterocyclic compound or salt thereof - Google Patents

Nitrogen-containing heterocyclic compound or salt thereof

Info

Publication number
NZ717329A
NZ717329A NZ717329A NZ71732913A NZ717329A NZ 717329 A NZ717329 A NZ 717329A NZ 717329 A NZ717329 A NZ 717329A NZ 71732913 A NZ71732913 A NZ 71732913A NZ 717329 A NZ717329 A NZ 717329A
Authority
NZ
New Zealand
Prior art keywords
salt
containing heterocyclic
heterocyclic compound
nitrogen
flt3
Prior art date
Application number
NZ717329A
Inventor
Masaru Takasaki
Toshiaki Tsujino
Shintarou TANABE
Megumi Ookubo
Kimihiko Sato
Atsushi Hirai
Daisuke Terada
Shinsuke INUKI
Shinsuke Mizumoto
Original Assignee
Fujifilm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corp filed Critical Fujifilm Corp
Publication of NZ717329A publication Critical patent/NZ717329A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The object is to provide an Fms-like tyrosine kinase 3 (FLT3) inhibitor useful as a therapeutic agent for acute myeloid leukemia (AML). A novel nitrogen-containing heterocyclic compound represented by the general formula [1] or a salt thereof is provided. The compound or a salt thereof of the present invention can be used as an active ingredient of a pharmaceutical composition for a treatment of a disease or condition relating to FLT3, such as acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL).
NZ717329A 2012-04-17 2013-04-16 Nitrogen-containing heterocyclic compound or salt thereof NZ717329A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012094184 2012-04-17
JP2013082479 2013-03-15
NZ70185513 2013-04-16

Publications (1)

Publication Number Publication Date
NZ717329A true NZ717329A (en) 2016-09-30

Family

ID=56989734

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ717329A NZ717329A (en) 2012-04-17 2013-04-16 Nitrogen-containing heterocyclic compound or salt thereof

Country Status (1)

Country Link
NZ (1) NZ717329A (en)

Similar Documents

Publication Publication Date Title
MX358311B (en) Nitrogen-containing heterocyclic compound or salt thereof.
MX2015010971A (en) Novel pyrazole derivative.
NZ620208A (en) Substituted n-[1-cyano-2-(phenyl)ethyl]-2-azabicyclo[2,2,1]heptane-3-carboxamide inhibitors of cathepsin c
TN2015000034A1 (en) Derivatives of azaindazole or diazaindazole type for treating pain
GEP20156285B (en) Compounds and compositions as trk inhibitors
GEP20146125B (en) Aminopyrimidines as syk inhibitors
PH12014502586A1 (en) Novel ring-substituted n-pyridinyl amides as kinase inhibitors
NZ612000A (en) Bicyclo[3.2.1]octyl amide derivatives and uses of same
GEP20146102B (en) Compounds and compositions as protein kinase inhibitors
MX2010014234A (en) Pyrazole compounds 436.
GEP20166443B (en) Heterocyclic compound and use thereof
MX2012002179A (en) Heterocyclic oxime compounds.
MX358961B (en) C7-fluoro substituted tetracycline compounds.
MX2015016421A (en) Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease.
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
MX2016008665A (en) 1,2-naphthoquinone derivative and method for preparing same.
MY167898A (en) Co-crystals and salts of ccr3-inhibitors
GEP20166481B (en) (crystalline forms of hydrochloride salt of (4a-r, 9a-s)-1-(1h-benzoimidazole-5-carbonyl)-2, 3, 4, 4a, 9, 9a-hexa- hydro-1h-indeno [2, 1-b] pyridine-6-carbonitrile and their use as hsd 1 inhibitors
MX2021010046A (en) A new therapeutical composition containing apomorphine as active ingredient.
IN2012DN02502A (en)
MX364400B (en) Tetracycline compounds.
PH12018500378A1 (en) Novel annelated phenoxyacetamides
MX2021013576A (en) Compound used as kinase inhibitor and application thereof.
MX2018010177A (en) 6,7-dihydro-5h-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds.
MY153733A (en) Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 16 APR 2018 BY BALDWINS INTELLECTUAL PROPERTY

Effective date: 20170313

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 16 APR 2019 BY CPA GLOBAL

Effective date: 20180302

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 16 APR 2020 BY CPA GLOBAL

Effective date: 20190228

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 16 APR 2021 BY CPA GLOBAL

Effective date: 20200306

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 16 APR 2022 BY CPA GLOBAL

Effective date: 20210305

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 16 APR 2023 BY CPA GLOBAL

Effective date: 20220304

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 16 APR 2024 BY CPA GLOBAL

Effective date: 20230303